4.7 Review

Effects of brain radiotherapy on cognitive performance in adult low-grade glioma patients: A systematic review

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 160, Issue -, Pages 202-211

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2021.04.023

Keywords

Low grade gliomas; Radiation therapy; Adults; Cognitive deficit; Quality of Life; Grade II gliomas

Ask authors/readers for more resources

The debate over the role of radiation therapy in managing grade II gliomas remains ongoing, with studies providing contradictory data regarding the cognitive effects on patients. While some research indicates potential long-term cognitive deficits following radiation therapy, there is insufficient evidence to suggest that current protocols significantly impact cognitive decline in these patients. Additional high-quality prospective studies are needed to further investigate this issue.
Grade II gliomas are slow growing tumours that usually affect younger patients. The mainstream treatment modality at present is surgical. The role of radiation therapy in the management of grade II gliomas has been the subject of considerable debate. Radiation therapy has a proven potential to prolong progression free and overall survival in high-risk patients, but may also produce long-term cognitive deficits. Since grade II glioma patients are expected to live several years, retention of cognitive capacity and quality of life is an equally important endpoint as prolonging progression free survival. Our overarching goal is to critically review the available evidence on the possible neuropsychological effects of postoperative radiotherapy in adult grade II glioma patients. We performed a systematic literature search in Medline, Embase and Cochrane databases up to 1st of May 2020 for studies assessing the cognitive effects of radiation therapy on grade II glioma patients. Eleven studies meeting our inclusion criteria provide either negative or contradictory data regarding the cognitive domains affected, while major confounding variables remain incompletely addressed. The available evidence does not adequately support the notion that current radiation therapy protocols independently produce substantial cognitive decline in grade II glioma patients and therefore it would be premature to argue that radiation associated cognitive morbidity outweighs the benefit of prolonged survival. A large prospective study incorporating a full battery of neuropsychological testing, sufficiently long-term follow-up period and tight control of confounders is due to provide high quality data. CO 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 160 (2021) 202-211

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available